Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer
ClinicalTrials.gov study NCT02105350. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT07252375. IPD Sharing: NO. Countries: 0. Publications: 0.
Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas
ClinicalTrials.gov study NCT00005591. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer
ClinicalTrials.gov study NCT00055432. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer
ClinicalTrials.gov study NCT00532285. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLC
ClinicalTrials.gov study NCT04331626. IPD Sharing: NO. Countries: 0. Publications: 0.
A Single-arm Study of Gemcitabine, Cisplatin, and Nab-Paclitaxel as Neoadjuvant Therapy for Resectable Oncologically High-Risk IHCC in Korea
ClinicalTrials.gov study NCT04546828. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT00307723. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine
ClinicalTrials.gov study NCT00560963. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
ClinicalTrials.gov study NCT00034593. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer
ClinicalTrials.gov study NCT00014287. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma
ClinicalTrials.gov study NCT00044031. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas
ClinicalTrials.gov study NCT00116389. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00278460. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder
ClinicalTrials.gov study NCT02723838. IPD Sharing: NO. Countries: 0. Publications: 0.
Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial
ClinicalTrials.gov study NCT02440958. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Milciclib in Combination With Gemcitabine in Advanced NSCLC
ClinicalTrials.gov study NCT05651269. IPD Sharing: NO. Countries: 0. Publications: 0.
A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT00301301. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.
ClinicalTrials.gov study NCT00034489. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00540280. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.